Pentamer staining in patients with GVHD but without CRC
. | . | % CEA-Cap1+/CD8+ cells during GVHD . | . | |
|---|---|---|---|---|
| ID no. . | Disease . | GI . | Other sites . | |
| 1 | Myeloma | 0.09 | — | |
| 2 | Myeloma | 0.11 | — | |
| 3 | Myeloma | 0.19 | — | |
| 4 | Renal carcinoma | 0.12 | — | |
| 5 | Renal carcinoma | 0.13 | — | |
| 6 | Myeloma | — | 0.09 | |
| 7 | Myeloma | — | 0.15 | |
| 8 | Myeloma | — | 0.16 | |
| 9 | Renal carcinoma | — | 0.08 | |
. | . | % CEA-Cap1+/CD8+ cells during GVHD . | . | |
|---|---|---|---|---|
| ID no. . | Disease . | GI . | Other sites . | |
| 1 | Myeloma | 0.09 | — | |
| 2 | Myeloma | 0.11 | — | |
| 3 | Myeloma | 0.19 | — | |
| 4 | Renal carcinoma | 0.12 | — | |
| 5 | Renal carcinoma | 0.13 | — | |
| 6 | Myeloma | — | 0.09 | |
| 7 | Myeloma | — | 0.15 | |
| 8 | Myeloma | — | 0.16 | |
| 9 | Renal carcinoma | — | 0.08 | |
— indicates no GVHD involvement in that site.